Articles From: - Shirley A. Weis Joins RTI Surgical Board of Directors to 2014/10/22 - New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease


RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that Shirley A.
Sign-up for - Shirley A. Weis Joins RTI Surgical Board of Directors investment picks
Amphenol Corporation (NYSE:APH) reported today third quarter 2014 diluted earnings per share excluding one-time items of $0.58 compared to $0.49 for the comparable 2013 period.
Sign-up for - Third Quarter 2014 Record Results Reported by Amphenol Corporation investment picks
State Street Global Advisors (SSGA), the asset management business of State Street Corporation (NYSE: STT), today announced the appointment of Lori Heinel, CFA, as chief portfolio strategist.
Sign-up for - State Street Global Advisors Appoints Chief Portfolio Strategist investment picks
United Community Financial Corp.
Sign-up for - United Community Financial Corp. Posts Another Strong Quarter investment picks
California Resources Corporation , a subsidiary of Occidental Petroleum Corporation (NYSE:OXY), announced net income of $188 million for the third quarter of 2014, compared with $235 million for the third quarter of 2013.
Sign-up for - California Resources Corporation Announces 3rd Quarter and Nine Month 2014 Financial Results investment picks
OpenText Reports First Quarter Fiscal Year 2015 Financial Results Canada NewsWire WATERLOO, Ontario , Oct.
Sign-up for - OpenText Reports First Quarter Fiscal Year 2015 Financial Results investment picks
SAN DIEGO and NEW YORK, Oct.
Sign-up for - Robbins Arroyo LLP: Retrophin, Inc. (RTRX) Misled Shareholders According to a Recently Filed Class Action investment picks
OMAHA, Neb., Oct.
Sign-up for - Green Plains to Discuss Third Quarter 2014 Financial Results investment picks
- Solid earnings across all business segments - Strong annuity sales continued, led by new fixed indexed annuity product - Book value per share excluding the fair value adjustment for investments of $24.91, up 8% compared to a year ago - Raising full year 2014 operating income guidance to $2.20 to $2.30 per diluted share SPRINGFIELD, Ill.
Sign-up for - Horace Mann Reports Third Quarter 2014 Operating EPS Of $0.55 investment picks
Phillips 66 Partners LP (NYSE:PSXP) (the “Partnership”) has reached an agreement to acquire from Phillips 66 (NYSE:PSX) two newly constructed crude oil rail-unloading facilities, located in Linden, New Jersey, and Ferndale, Washington, for $330 million as well as certain assets associated with the Cross-Channel Connector Pipeline for an additional $10 million.
Sign-up for - Phillips 66 Partners Announces Acquisition of Strategic Logistics Assets investment picks
LOS ALTOS, Calif., Oct.
Sign-up for - DSP Group Delivers HD Voice and Home Automation Utilizing Qualcomm Internet Processor investment picks
2014/10/22
Highlights - Net income increase of 29.2%. Third quarter net income was $1,552,000 ($0.23 per share) as compared to $1,201,000 ($0.18 per share) in the prior quarter.
Sign-up for 2014/10/22 - First Community Corporation Announces Third Quarter Results and Cash Dividend investment picks
EMPLOYERS ® (NYSE:EIG), America's small business insurance specialist ® , today announced that Ranney Pageler, vice president of fraud investigations, has been named chair of the Property Casualty Insurers Association of America (PCI) Fraud Committee.
Sign-up for - EMPLOYERS’ Ranney Pageler Named Chair of the Property Casualty Insurers Association of America Fraud Committee investment picks
SAN DIEGO, Oct.
Sign-up for - Royale Confirms New High Rate Well investment picks
SOUTH SAN FRANCISCO, Calif., Oct.
Sign-up for - OXiGENE Announces Third Quarter 2014 Earnings Conference Call and Webcast investment picks
Alkermes plc (NASDAQ: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for aripiprazole lauroxil, the company’s investigational, novel, once-monthly injectable atypical antipsychotic for the treatment of schizophrenia.
Sign-up for - Alkermes’ New Drug Application for Aripiprazole Lauroxil for Treatment of Schizophrenia Accepted for Filing by U.S. FDA investment picks
Zendesk, Inc. (NYSE: ZEN) today launched its built-in Net Promoter Score® (NPS) surveys, allowing organizations to measure customer loyalty and gather insights to improve their long-term customer relationships.
Sign-up for - Zendesk Launches Net Promoter Score® Surveys and Unveils Customer Loyalty Trends investment picks
2014/10/22
In the news release, LIFDEK Launches Revolutionary Corrugated Pallet System, issued 22-Oct-2014 by Lifdek Corporation over PR Newswire, the source line should read "Lifdek Corporation; Veritiv Corporation" rather than "Lifdek Corporation; ?Veritiv Corporation" as incorrectly transmitted by PR Newswire.
Sign-up for 2014/10/22 - /C O R R E C T I O N -- Lifdek Corporation/ investment picks
Revenues, excluding divestitures, grew 8% sequentially EPS of $0.32 (non-GAAP) improved 33% sequentially Incremental operating income of 48% on sequential revenue growth Reduction in Net Debt of $717 million BAAR, Switzerland , Oct.
Sign-up for - Weatherford Reports Third Quarter 2014 Results investment picks
TOWNSHIP OF WASHINGTON, N.J., Oct.
Sign-up for - Oritani Financial Corp. Announces Dividend and Quarterly Results investment picks
CHICAGO , Oct.
Sign-up for - Morningstar, Inc. Reports Third-Quarter 2014 Financial Results investment picks
2014/10/22
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G024385-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/22/11G024385/convertedPNGlogo-1912507502.jpg PITTSBURGH, PA--(Marketwired - October 22, 2014) - Geospatial Corporation (PINKSHEETS: GSPH) announced today that it has recently filed an amended S-1 Registration Statement.
Sign-up for 2014/10/22 - Geospatial Corporation Files Amended S-1 Registration investment picks
2014/10/22
Immune Pharmaceuticals Recently Initiated Phase II Clinical Trial in Ulcerative Colitis CAMBRIDGE, Mass.
Sign-up for 2014/10/22 - New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: - Shirley A. Weis Joins RTI Surgical Board of Directors to 2014/10/22 - New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent